cyclosporine and Acrania

cyclosporine has been researched along with Acrania in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (14.29)	18.2507
2000's	5 (71.43)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Acar, H; Fazliogullari, Z; Karabulut, AK; Unver Dogan, N; Uysal, II	1
Hamano, Y; Ikeda, Y; Ishihara, D; Kawamura, J; Mori, T; Okamoto, S; Sato, N; Watanabe, R	1
Baker, JC; Borchers, A; Fonar, Y; Frank, D	1
Alessandrino, PE; Bacigalupo, A; Barisione, G; Bosi, A; Bruno, B; Bruzzi, P; di Bartolomeo, P; Guidi, S; Lamparelli, T; Oneto, R; Sacchi, N; van Lint, MT	1
Goldman, AS; Goto, MP; Uhing, MR	1
Cantú, OG; Gómez-Almaguer, D; González-Llano, O; Jaime-Pérez, JC; Ruiz-Argüelles, A; Ruiz-Argüelles, GJ	1
Inoue , K; Kawahito, Y; Sano, H; Yoshikawa, T	1

Trials

1 trial(s) available for cyclosporine and Acrania

Article	Year
Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2006, Volume: 12, Issue:5 Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Cause of Death; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Forced Expiratory Volume; Graft vs Host Disease; Humans; Immunosuppressive Agents; Incidence; Karnofsky Performance Status; Leukemia; Life Tables; Lung Diseases; Male; Methotrexate; Middle Aged; Neural Tube Defects; Premedication; Prospective Studies; Recurrence; Survival Analysis; T-Lymphocytes; Transplantation, Homologous; Treatment Outcome; Vital Capacity	2006

Article

Year

Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2006, Volume: 12, Issue:5

Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Cause of Death; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Forced Expiratory Volume; Graft vs Host Disease; Humans; Immunosuppressive Agents; Incidence; Karnofsky Performance Status; Leukemia; Life Tables; Lung Diseases; Male; Methotrexate; Middle Aged; Neural Tube Defects; Premedication; Prospective Studies; Recurrence; Survival Analysis; T-Lymphocytes; Transplantation, Homologous; Treatment Outcome; Vital Capacity

2006

Other Studies

6 other study(ies) available for cyclosporine and Acrania

Article	Year
Investigation of developmental toxicity and teratogenicity of cyclosporine A, tacrolimus and their combinations with prednisolone. Regulatory toxicology and pharmacology : RTP, 2016, Volume: 77 Topics: Abnormalities, Drug-Induced; Animals; Apoptosis; Cyclosporine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Embryo Culture Techniques; Embryo, Mammalian; Female; Gestational Age; Hematoma; Humans; Immunosuppressive Agents; Neural Tube Defects; Prednisolone; Pregnancy; Rats, Wistar; Risk Assessment; Tacrolimus; Teratogens; Toxicity Tests	2016
Recurrent acute myositis after allogeneic bone marrow transplantation for myelodysplasia. Hematology (Amsterdam, Netherlands), 2002, Volume: 7, Issue:2 Topics: Bone Marrow Transplantation; Cyclosporine; Female; Humans; Immune System; Leukemia, Myeloid, Acute; Middle Aged; Myositis; Neural Tube Defects; Recurrence; Transplantation, Homologous	2002
XNF-ATc3 affects neural convergent extension. Development (Cambridge, England), 2006, Volume: 133, Issue:9 Topics: Animals; Body Patterning; Cyclosporine; Dose-Response Relationship, Drug; Ectoderm; Embryo, Nonmammalian; Enzyme Inhibitors; Mesoderm; Models, Biological; Neural Tube Defects; NFATC Transcription Factors; Organ Culture Techniques; Xenopus; Xenopus Proteins	2006
Cyclosporin A-induced embryopathy in embryo culture is mediated through inhibition of the arachidonic acid pathway. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1993, Volume: 202, Issue:3 Topics: Abnormalities, Drug-Induced; Animals; Arachidonic Acid; Culture Techniques; Cyclosporine; Dinoprostone; Dose-Response Relationship, Drug; Embryo, Mammalian; Embryonic and Fetal Development; Head; Mice; Neural Tube Defects; Proteins; Regression Analysis	1993
Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens. American journal of hematology, 2001, Volume: 66, Issue:4 Topics: Adolescent; Adult; Ambulatory Care; Busulfan; Child; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Neural Tube Defects; Program Evaluation; Recurrence; Survival Analysis; Thalassemia; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine	2001
What is proper treatment for Wegener granulomatosis? Archives of internal medicine, 2001, Jul-23, Volume: 161, Issue:14 Topics: Adult; Cyclophosphamide; Cyclosporine; Cystitis; Disease Progression; Female; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Neural Tube Defects; Recurrence; Treatment Refusal; Urinary Bladder Neoplasms	2001